- Home
- DCGO vs PACB Comparison
DCGO vs PACB Comparison
Compare DCGO & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- PACB
- Stock Information
- Founded
- DCGO 2015
- PACB 2000
- Country
- DCGO United States
- PACB United States
- Employees
- DCGO N/A
- PACB N/A
- Industry
- DCGO Managed Health Care
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- DCGO Health Care
- PACB Industrials
- Exchange
- DCGO Nasdaq
- PACB Nasdaq
- Market Cap
- DCGO 417.4M
- PACB 452.1M
- IPO Year
- DCGO N/A
- PACB 2010
- Fundamental
- Price
- DCGO $4.12
- PACB $1.77
- Analyst Decision
- DCGO Strong Buy
- PACB Buy
- Analyst Count
- DCGO 5
- PACB 15
- Target Price
- DCGO $6.10
- PACB $2.92
- AVG Volume (30 Days)
- DCGO 730.0K
- PACB 12.4M
- Earning Date
- DCGO 11-07-2024
- PACB 11-07-2024
- Dividend Yield
- DCGO N/A
- PACB N/A
- EPS Growth
- DCGO 300.38
- PACB N/A
- EPS
- DCGO 0.29
- PACB N/A
- Revenue
- DCGO $694,968,328.00
- PACB $173,147,000.00
- Revenue This Year
- DCGO $1.17
- PACB N/A
- Revenue Next Year
- DCGO N/A
- PACB $25.88
- P/E Ratio
- DCGO $14.44
- PACB N/A
- Revenue Growth
- DCGO 30.19
- PACB 2.14
- 52 Week Low
- DCGO $2.75
- PACB $1.16
- 52 Week High
- DCGO $6.21
- PACB $10.65
- Technical
- Relative Strength Index (RSI)
- DCGO 65.99
- PACB 43.55
- Support Level
- DCGO $3.84
- PACB $1.49
- Resistance Level
- DCGO $4.43
- PACB $2.66
- Average True Range (ATR)
- DCGO 0.26
- PACB 0.30
- MACD
- DCGO 0.02
- PACB -0.08
- Stochastic Oscillator
- DCGO 71.63
- PACB 22.76
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.